SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001564590-20-016154
Filing Date
2020-04-09
Accepted
2020-04-09 17:29:03
Documents
3
Period of Report
2020-05-27

Document Format Files

Seq Description Document Type Size
1 PRE 14A apvo-pre14a_20200527.htm PRE 14A 928430
2 GRAPHIC gvgntrvvqkv1000001.jpg GRAPHIC 86252
3 GRAPHIC gvgntrvvqkv1000002.jpg GRAPHIC 76707
  Complete submission text file 0001564590-20-016154.txt   1154123
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37746 | Film No.: 20785515
SIC: 2834 Pharmaceutical Preparations